Skip to main content
. 2020 Apr 8;87(3):538–546. doi: 10.1093/neuros/nyaa054

TABLE 1.

Patient Characteristics

Factor N (%)
Female sex 46 (45%)
Median age, yr (IQR) 49 (37-59)
Median maximum tumor diameter, mm (IQR) 20 (17-28)
History of prior resection 100 (98%)
Pre-SRS anterior pituitary deficit 20 (20%)
Baseline acromegaly laboratory studies
 GH, ng/mL (IQR) 4.7 (1.88-9.58)
 IGF-1, ng/mL (IQR) 552 (189-1244)
 IGF-1ia, scale (IQR) 1.66 (1.37-3.22)
 IGF-1i ≥ 2.25 31 (30%)
Total post-SRS endocrine and radiographic 63 (29-100)
follow-up, mo (IQR)

GH, growth hormone; IGF-1, insulin-like growth factor-1; IQR, interquartile range; SRS, stereotactic radiosurgery.

aIGF-1i is defined as patient laboratory value divided by their age- and sex-adjusted upper limit of normal.